U.S. patent number D422,749 [Application Number D/085,319] was granted by the patent office on 2000-04-11 for detergent tablet. This patent grant is currently assigned to Colgate-Palmolive Company. Invention is credited to Gary Benjamin Binstock, Bruce Cummings, Divaker Kenkare, Kevin Mark Kinscherf, Steve Mark Phillips.
United States Patent | D422,749 |
Binstock , et al. | April 11, 2000 |
Inventors: | Binstock; Gary Benjamin (Basking Ridge, NJ), Cummings; Bruce (New York, NY), Kenkare; Divaker (Califon, NJ), Kinscherf; Kevin Mark (Freehold, NJ), Phillips; Steve Mark (Highland Park, NJ) |
---|---|
Assignee: | Colgate-Palmolive Company (New
York, NY) |
Appl. No.: | D/085,319 |
Filed: | March 20, 1998 |
Current U.S. Class: | D28/8.1 |
Current International Class: | 2803 |
Field of Search: | ;D28/8.1,8.2 ;D23/207,208 ;D24/100-104 ;510/137-149,440,446-449,224,225 ;424/457-474 |
D217889 | June 1970 | Koenigsberg |
237861 | February 1881 | Hare |
D269721 | July 1983 | Tovey |
D283931 | May 1986 | Baum |
D285490 | September 1986 | Tovey |
D286086 | October 1986 | Tovey |
D298062 | October 1988 | Bussell |
D301762 | June 1989 | Oshlack |
D376643 | December 1996 | Hatton et al. |
D403396 | December 1998 | Lundbom et al. |
790319 | May 1905 | Samuel |
1981249 | November 1934 | Rosenblatt |
2271959 | February 1942 | Swanson |
3557003 | January 1971 | Morris et al. |
4253842 | March 1981 | Erlich |
4460490 | July 1984 | Barford et al. |
4578207 | March 1986 | Holdt et al. |
4946685 | August 1990 | Edgren et al. |
5084277 | January 1992 | Greco et al. |
5262132 | November 1993 | Bricker et al. |
292291 | Jun 1928 | GB | |||
Australian Trade Mark No. 36,569, registered Jul. 17, 1923. . Drug Standards Sep./Oct. 1959, p. 126: tablet and capsule shapes in rows A and B. . Blair Co. Cat No. 766 of 1969, p. 24: soaps indicated by arrows. . Physician's Desk Reference 49 Edition 1995; 1) p. 305: Demadex.TM. 100 mg tablet on right 2) p. 330: Flagyl.RTM. 500 mg tablet 3) p. 331: Ralefen.RTM. 750 mg tablet 4) p. 334: Motrin.RTM. 600 & 800 mg tablets.. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.